Table 3

Impact of individual concordant and discordant conditions on diabetes testing goal achievement, adjusted, OR (95% CI), with prevalence of conditions, among patients with diabetes age 18–75

		Diabetes care goal achieved
	Prevalence % (n=23 430)	HbA1c testing		LDL testing		Kidney testing
	Prevalence % (n=23 430)	OR (95% CI)	p Value	OR (95% CI)	p Value	OR (95% CI)	p Value
Lack of testing goal achievement
Congestive heart failure	5.0			0.6 (0.5 to 0.8)	0.0000
Substance use disorders	0.8			0.6 (0.4 to 0.8)	0.0010
Anemia	0.4			0.4 (0.2 to 0.7)	0.0020
Testing goal achievement
Hyperlipidemia	77	1.4 (1.3 to 1.5)	0.0000	2.9 (2.7 to 3.2)	0.0000	1.4 (1.3 to 1.5)	0.0000
Hypertension	74	1.1 (1.03 to 1.2)	0.0060
Obesity	22	1.2 (1.1 to 1.3)	0.0000
Thyroid disorder	15	1.2 (1.1 to 1.3)	0.0010
Coronary atherosclerosis	14			1.3 (1.1 to 1.5)	0.0010
Renal failure	11	1.3 (1.2 to 1.5)	0.0000			29.1 (18.6 to 45.4)	0.0000
CNS/PNS disorders*	7.8	1.2 (1.1 to 1.4)	0.0060
Kidney and vesicoureteral disorders†	4.8					2 (1.5 to 2.7)	0.0000
Menopause and perimenopause	3.6			1.5 (1.1 to 1.9)	0.0030

Bold represents conditions associated with lack of goal achievement.
Adjusted for age, sex, race, insurance, number of face-to-face office visits in the baseline year, patient rural–urban commuting area, per cent with diabetes in patient’s county, per cent of Medicare patients with diabetes in patient’s county who achieved HbA1c testing, per cent below poverty line in patient’s zip code, per cent without high school education in patient’s zip code, health system.
All 62 conditions were included in the model. Only conditions with significant associations at p value<0.01 are listed in the table. All conditions are mutually exclusive.
*Excludes malignancies, multiple sclerosis and epilepsy.
‡Excludes kidney failure.
CNS/PNS, central nervous system and peripheral nervous system; HbA1c, glycated haemoglobin.